Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners. AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the following investor conferences: Piper Sandler 36th Annual Healthcare Conference in New York, NY on...
AbCellera (Nasdaq: ABCL) today announced new data on its T-cell engager (TCE) platform, to be presented as a poster at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting at the...
AbCellera (Nasdaq: ABCL) today announced financial results for the third quarter of 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise...
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will be presenting at the following investor conferences: Stifel Healthcare Conference on Monday, November 18, 2024, at...
AbCellera (Nasdaq: ABCL) today announced an upcoming poster presentation on its T-cell engager platform at the SITC 39th Annual Meeting, to be held November 6 to 10 at the George R. Brown...
AbCellera (Nasdaq: ABCL) will announce its third quarter 2024 financial results on Monday, November 4, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.1783 | 6.14827586207 | 2.9 | 3.0783 | 2.79 | 2860859 | 2.94202025 | CS |
| 4 | 0.2283 | 8.01052631579 | 2.85 | 3.085 | 2.62 | 2643177 | 2.8837148 | CS |
| 12 | 0.5483 | 21.6719367589 | 2.53 | 3.18 | 2.41 | 2431638 | 2.84261024 | CS |
| 26 | 0.2783 | 9.93928571429 | 2.8 | 3.6 | 2.335 | 2053664 | 2.78016545 | CS |
| 52 | -2.5417 | -45.2259786477 | 5.62 | 6.055 | 2.335 | 1767237 | 3.42507409 | CS |
| 156 | -11.3917 | -78.7263303386 | 14.47 | 14.97 | 2.335 | 1969940 | 6.96721767 | CS |
| 260 | -57.9217 | -94.9536065574 | 61 | 71.91 | 2.335 | 1900312 | 10.80839924 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
